Cargando…
Corrigendum to: Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209284/ https://www.ncbi.nlm.nih.gov/pubmed/34151265 http://dx.doi.org/10.1093/braincomms/fcab103 |
Ejemplares similares
-
Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
por: Ye, Zimeng, et al.
Publicado: (2021) -
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
Publicado: (2018) -
Corrigendum to “Alzheimer's Disease Dementia as the Diagnosis Best Supported by the Cerebrospinal Fluid Biomarkers: Difference in Cut-Off Levels from Thai Experience”
por: Senanarong, Vorapun, et al.
Publicado: (2017) -
ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer
por: Escudero, Laura, et al.
Publicado: (2021) -
Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
Publicado: (2023)